How to ensure clinical trials continuity without compromising patient’s safety and data quality.

To meet their study demands the Sponsor has chosen Data MATRIX EDC to deliver flexible, intuitive, cost-effective and bespoke solutions for its NIS (Non Interventional Study).

Complicated randomization with three treatment groups in a double-blind study in patients with colorectal cancer. We took into account a central assessor who performed a tumor growth assessment, an absence of investigational drug products in stock and a need for intermediate reporting.

A randomized, single-blind clinical study in two parallel groups with very tight deadlines for collection, processing and submission of data. The project supposed to include special external study questionnaires, unblinded employee, and no randomization numbers.

Individual selection of the modules for an observational multicenter study in infectious diseases. Data MATRIX team reduced the number of created data correction queries by 20%, performed verification of the final statistical study report, and prepared the final clinical study report.